Video

Combining Local and Systemic Therapies in Liver Cancer

Author(s):

Ghassan K. Abou-Alfa, M.D.

Can local and systemic therapies be combined to treat liver cancer?

Ghassan K. Abou-Alfa, M.D., medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the future of combining local and systemic therapy to treat liver cancer.

Currently, there is a divide between local (delivered directly to the tumor) therapy and systemic (given throughout the whole body) therapy in the treatment of liver cancer. However, Abou-Alfa said, "This is about marriage, not divorce," between the two treatment methods, and expects combination regimens to emerge on the scene.

Related Videos
Image of man with black hair.
Image of a man with dark hair and some facial hair.
Image of a man with blond facial hair.
Image of woman with blonde hair.
Image of a woman with long red hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with short black hair.
Related Content
Illustration of woman with blonde hair.
November 20th 2024

What Patients with Breast Cancer Need to Know About Lymphedema Risk

Alex Biese
CURE® spoke with a physical therapist specializing in oncology to find out more about this condition some patients with cancer are at risk for.
Marshall Morris, the founder of Dying Defiantly
December 8th 2022

Creating a Charity 8 Days After a Rare Cancer Diagnosis: Dying Defiantly Founder Shares His Story

Sailaja Darisipudi Andy Polhamus
After Marshall Morris was diagnosed with a rare cancer and given only six months to live, he created a charity that empowers people with terminal illness and provides them with counseling and support.
Image of a woman with short blonde hair, wearing a colorful striped shirt.
November 19th 2024

Why Clinical Trials Don’t Have to Be Patients’ ‘Last Line of Defense’

Alex Biese
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients with cancer to enroll.
Making Art From Cancer
December 10th 2020

Making Art From Cancer

Jessica Skarzynski
This week on the “CURE® Talks Cancer” podcast, we spoke with renowned street artist James Cochran about one of his art projects that was commissioned to symbolize the creativity and commitment of those who work tirelessly to eradicate cancer.
Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved relapse-free survival.
November 14th 2024

ICI Response May Predict Relapse-Free Survival in Liver Cancer

Alex Biese
Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved relapse-free survival.
Liver Cancer
November 14th 2024

A Phase 3 Trial of Amezalpat in Advanced Liver Cancer Receives Study May Proceed Letter

Ryan Scott
For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study May Proceed” letter from the FDA.